Cytogenetic abnormalities and monosomal karyotypes in children and adolescents with acute myeloid leukemia: Correlations with clinical characteristics and outcome

Cancer Genetics

Volumn 206, Issue 3, 2013, Pages 63-72

  Manola, Kalliopi N ^a   Panitsas, Fotios ^b   Polychronopoulou, Sophia ^c   Daraki, Aggeliki ^a   Karakosta, Maria ^a   Stavropoulou, Cryssa ^a   Avgerinou, Georgia ^c   Hatzipantelis, Emmanuel ^d   Pantelias, Gabriel ^a   Sambani, Constantina ^a   Pagoni, Maria ^b  

^a INSTITUTE OF NANOSCIENCE AND NANOTECHNOLOGY   (Greece)

^b EVANGELISMOS HOSPITAL   (Greece)

^c AGHIA SOPHIA CHILDREN S HOSPITAL   (Greece)

^d Aristotle University and Hippokration General Hospital   (Greece)

Author keywords

Childhood and adolescent AML; Cytogenetics; Monosomal karyotypes; Outcome

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADOLESCENT DISEASE; ARTICLE; CANCER PROGNOSIS; CANCER SURVIVAL; CARCINOGENESIS; CHILD; CHILDHOOD LEUKEMIA; CHROMOSOME 11Q; CHROMOSOME 11Q23; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CHROMOSOME DELETION; CHROMOSOME DELETION 11P; CHROMOSOME DELETION 12P; CHROMOSOME DELETION 1P; CHROMOSOME DELETION 20Q; CHROMOSOME DELETION 5; CHROMOSOME DELETION 6Q; CHROMOSOME DELETION 7P; CHROMOSOME REARRANGEMENT; CLINICAL FEATURE; COHORT ANALYSIS; CORRELATIONAL STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; INDUCTION CHEMOTHERAPY; INFANT; KARYOTYPE; LEUKEMIA REMISSION; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; METAPHASE CHROMOSOME; MONOSOMY 7; MYELODYSPLASTIC SYNDROME; OVERALL SURVIVAL; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SURVIVAL TIME;

ACUTE DISEASE; ADOLESCENT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD; CHILD, PRESCHOOL; CHROMOSOME ABERRATIONS; COHORT STUDIES; HUMANS; INFANT; KAPLAN-MEIER ESTIMATE; KARYOTYPE; KARYOTYPING; LEUKEMIA, ERYTHROBLASTIC, ACUTE; LEUKEMIA, MEGAKARYOBLASTIC, ACUTE; LEUKEMIA, MONOCYTIC, ACUTE; LEUKEMIA, MYELOID; LEUKEMIA, MYELOID, ACUTE; LEUKEMIA, MYELOMONOCYTIC, ACUTE; LEUKEMIA, PROMYELOCYTIC, ACUTE; MALE; MONOSOMY; PROGNOSIS; TRANSLOCATION, GENETIC; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84875898459     PISSN: 22107762     EISSN: 22107770     Source Type: Journal    
DOI: 10.1016/j.cancergen.2013.01.001     Document Type: Article

References (38)

1. Rubnitz J.E., Gibson B., Smith F.O. Acute myeloid leukemia. Hematol Oncol Clin North Am 2010, 24:35-63.
2. Meshinchi S., Arceci R.J. Prognostic factors and risk-based therapy in pediatric acute myeloid leukemia. The Oncologist 2007, 12:341-355.
3. Manola K.N. Cytogenetics of pediatric acute myeloid leukemia. Eur J Haematol 2009, 83:391-405.
4. Szczepański T., Harrison C.J., van Dongen J.J. Genetic aberrations in paediatric acute leukaemias and implications for management of patients. Lancet Oncol 2010, 11:880-889. Review.
5. Harrison C.J., Hills R.K., Moorman A.V., et al. Cytogenetics of childhood acute myeloid leukemia: United Kingdom Medical Research Council Treatment trials AML 10 and 12. J Clin Oncol 2010, 28:2674-2681.
6. von Neuhoff C., Reinhardt D., Sander A., et al. Prognostic impact of specific chromosomal aberrations in a large group of pediatric patients with acute myeloid leukemia treated uniformly according to trial AML-BFM 98. J Clin Oncol 2010, 28:2682-2689.
7. Verdeguer A. Genetic alterations in children and adolescents with acute myeloid leukaemia. Clin Transl Oncol 2010, 12:590-596.
8. Balgobind B.V., Hollink I.H., Arentsen-Peters S.T., et al. Integrative analysis of type-I and type-II aberrations underscores the genetic heterogeneity of pediatric acute myeloid leukemia. Haematologica 2011, 96:1478-1487.
9. Kayser S., Zucknick M., Döhner K., et al. Monosomal karyotype in adult acute myeloid leukemia: prognostic impact and outcome after different treatment strategies. Blood 2012, 119:551-558.
10. Tabori U., Revah G., Nathan P.C., et al. Toxicity and outcome of children with treatment related acute myeloid leukemia. Pediatr Blood Cancer 2008, 50:17-23.
11. Hijiya N., Ness K.K., Ribeiro R.C., et al. Acute leukemia as a secondary malignancy in children and adolescents: current findings and issues. Cancer 2009, 115:23-35. Review.
12. Swerdlow S.H., Campo E., Harris N.L., et al. WHO classification of tumours of the haematopoietic and lymphoid tissues 2008, WHO Press, Geneva, Switzerland. 4th edition.
13. Kaplan E., Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958, 53:457-481.
14. Cox D.R. Regression models and life tables (with discussion). J R Stat Soc 1972, 34:187-220.
15. Creutzig U., Büchner T., Sauerland M.C., et al. Significance of age in acute myeloid leukemia patients younger than 30 years: acommon analysis of the pediatric trials AML-BFM 93/98 and the adult trials AMLCG 92/99 and AMLHD93/98A. Cancer 2008, 112:562-571.
16. Razzouk B.I., Estey E., Pounds S., et al. Impact of age on outcome of pediatric acute myeloid leukemia. Cancer 2006, 106:2495-2502.
17. Lange B.J., Smith F.O., Feusner J., et al. Outcomes in CCG-2961, a Children's Oncology Group phase 3 trial for untreated pediatric acute myeloid leukemia: a report from the Children's Oncology Group. Blood 2008, 111:1044-1053.
18. Gregory J., Feusner J. Acute promyelocytic leukemia in childhood. Curr Oncol Rep 2009, 11:439-445. Review.
19. Rubnitz J.E., Lensing S., Razzouk B.I., et al. Effect of race on outcome of white and black children with acute myeloid leukemia: the St. Jude experience. Pediatr Blood Cancer 2007, 48:10-15.
20. Raimondi S.C., Chang M.N., Ravindranath Y., et al. Chromosomal abnormalities in 478 children with acute myeloid leukaemia: clinical characteristics and treatment outcome in a cooperative pediatric oncology group study-POG 8821. Blood 1999, 94:3707-3716.
21. Ravindranath Y., Chang M., Steuber C.P., et al. Pediatric Oncology Group (POG) studies of acute myeloid leukemia (AML): a review of four consecutive childhood AML trials conducted between 1981 and 2000. Leukemia 2005, 19:2101-2116.
22. Forestier E., Heim S., Blennow E., et al. Cytogenetic abnormalities in childhood acute myeloid leukaemia: a Nordic series comprising all children enrolled in the NOPHO-93-AML trial between 1993 and 2001. Br J Haematol 2003, 121:566-577.
23. Mrózek K., Heerema N.A., Bloomfield C.D. Cytogenetics in acute leukemia. Blood Rev 2004, 18:115-136.
24. Sierra M., Alonso A., Odero M.D., et al. Geographic differences in the incidence of cytogenetic abnormalities of acute myelogenous leukemia (AML) in Spain. Leuk Res 2006, 30:943-948.
25. Mantadakis E., Samonis G., Kalmanti M. A comprehensive review of acute promyelocytic leukemia in children. Acta Haematol 2008, 119:73-82.
26. Manola K.N., Karakosta M., Sambani C., et al. Isochromosome der(17)(q10)t(15;17) in acute promyelocytic leukemia resulting in an additional copy of the RARA-PML fusion gene: report of 4 cases and review of the literature. Acta Haematol 2010, 123:162-170. Review.
27. Stavropoulou C., Georgakakos V.N., Manola K.N., et al. 5'RARA submicroscopic deletion from new variant translocation involving chromosomes 15, 17, and 18, in a case of acute promyelocytic leukemia. Cancer Genet Cytogenet 2008, 182:50-55.
28. Pagoni M., Garofalaki M., Panitsas F., et al. Acute promyelocytic leukemia: an experience on 95 greek patients treated in the all-transretinoic Acid era. Mediterr J Hematol Infect Dis 2011, 3:e2011053.
29. Hasle H., Alonzo T.A., Auvrignon A., et al. Monosomy 7 and deletion 7q in children and adolescents with acute myeloid leukemia: an international retrospective study. Blood 2007, 109:4641-4647.
30. Chowdhury T., Brady H.J. Insights from clinical studies into the role of the MLL gene in infant and childhood leukaemia. Blood Cells Mol Dis 2008, 40:192-199.
31. Chen S.H., Yang C.P., Hung I.J., et al. Clinical features, molecular diagnosis, and treatment outcome of infants with leukemia in Taiwan. Pediatr Blood Cancer 2010, 55:1264-1271.
32. Balgobind B.V., Raimondi S.C., Harbott J., et al. Novel prognostic subgroups in childhood 11q23/MLL-rearranged acute myeloid leukemia: results of an international retrospective study. Blood 2009, 114:2489-2496.
33. Balgobind B.V., Zwaan C.M., Pieters R., et al. The heterogeneity of pediatric MLL-rearranged acute myeloid leukemia. Leukemia 2011, 1239-1248. Review.
34. Forestier E., Izraeli S., Beverloo B., et al. Cytogenetic features of acute lymphoblastic and myeloid leukemias in pediatric patients with Down syndrome: an IBFM-SG study. Blood 2008, 111:1575-1583.
35. Hama A., Yagasaki H., Takahashi Y., et al. Acute megakaryoblastic leukaemia (AMKL) in children: a comparison of AMKL with and without Down syndrome. Br J Haematol 2008, 140:552-561.
36. Fleǐshman E.V., Sokova O.I., Kirichenko O.P., et al. Complex karyotype abnormalities in pediatric acute myeloid leukemia. Vestn Ross Akad Med Nauk 2008, 5:3-7.
37. Aguilera D.G., Vaklavas C., Tsimberidou A.M., et al. Pediatric therapy-related myelodysplastic syndrome/acute myeloid leukemia: the MD Anderson Cancer Center experience. J Pediatr Hematol Oncol 2009, 31:803-811.
38. Barnard D.R., Woods W.G. Treatment-related myelodysplastic syndrome/acute myeloid leukemia in survivors of childhood cancer-an update. Leuk Lymphoma 2005, 46:651-663.